PharVision Advisers’s NNN REIT NNN Stock Holding History

PharVision Advisers’s Portfolio NNN Stock Details NNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,199	Closed	-$444K	–	466
2025 Q4	$444K	Buy	+11,199	New	+$459K	0.22%	76

Other funds holding NNN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

RIM

Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return

PharVision Advisers's NNN Position: Q1 2026 in Review

PharVision Advisers sold out of NNN REIT (NNN) in Q1 2026, closing a stake of 11,199 shares — an estimated $444K sold.

PharVision Advisers first reported a position in NNN in Q4 2025 and held it in 1 quarter. The position peaked at $444K in Q4 2025. 539 funds tracked by Wall St. Rank hold NNN as of Q1 2026.

PharVision Advisers reported no remaining NNN REIT position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 11,199 NNN REIT shares in Q1 2026, an estimated $444K.
PharVision Advisers first reported a position in NNN REIT in Q4 2025 and held it in 1 quarter.
PharVision Advisers's NNN REIT position peaked at $444K in Q4 2025.
539 funds tracked by Wall St. Rank held NNN REIT as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.